CARDIFF ONCOLOGY, INC. (CRDF) Gross margin 2016–2019
CARDIFF ONCOLOGY, INC. (CRDF) gross margin by fiscal year — reported gross profit divided by reported revenue.
100.0%FY2019 · since FY2016: -354.1% → 100.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2019 | 100.0% | +157.9 pp |
| FY2018 | -57.9% | +200.5 pp |
| FY2017 | -258.4% | +95.7 pp |
| FY2016 | -354.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CRDF financial trends
CRDF RevenueCRDF Net incomeCRDF Net marginCRDF Gross profitCRDF Operating incomeCRDF Operating marginCRDF Operating cash flowCRDF Free cash flowCRDF Capital expendituresCRDF Return on equityCRDF Stock buybacksCRDF Dividends paidCRDF Total assetsCRDF Total liabilitiesCRDF Shareholders’ equityCRDF overview →